Insider trading

Period: 120 months Stock: NBIX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

545 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

545 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

545 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

545 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
545 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
545 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

545 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
18 May 2017
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$532.70K 10,000 at 53.27
43.2%
18 May 2017
Lloyd-Smith Malcolm Chief Regulatory Officer
Sold, plan not stated
$265.23K 4,980 at 53.26
27.7%
5 May 2017
Sold, plan not stated
$269.90K 5,000 at 53.98
12.6%
2 May 2017
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated
$1.16M 21,739 at 53.23
6.1%
2 May 2017
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated
$550.00K 10,000 at 55.00
7.8%
1 May 2017
Gano Kyle Chief Business Development Off
Sold, plan not stated
$810.00K 15,000 at 54.00
17.0%
12 Apr 2017
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated 2×
$988.09K 19,596 at 50.42
5.6%
12 Apr 2017
OBrien Christopher Flint Chief Medical Officer
Sold, plan not stated 2×
$658.77K 13,065 at 50.42
21.1%
12 Apr 2017
Lloyd-Smith Malcolm Chief Regulatory Officer
Sold, plan not stated 2×
$658.77K 13,065 at 50.42
50.1%
Sold half or more
12 Apr 2017
Lippoldt Darin Chief Legal Officer
Sold, plan not stated 2×
$658.77K 13,065 at 50.42
49.8%
12 Apr 2017
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated 2×
$658.77K 13,065 at 50.42
9.3%
12 Apr 2017
Gano Kyle Chief Business Development Off
Sold, plan not stated 2×
$658.77K 13,065 at 50.42
15.1%
12 Apr 2017
Bozigian Haig P. Chief Development Officer
Sold, plan not stated 2×
$658.77K 13,065 at 50.42
9.2%
7 Feb 2017
BENEVICH ERIC Chief Commercial Officer
Sold, plan not stated
$5.89K 132 at 44.65
9.7%
7 Feb 2017
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$5.89K 132 at 44.62
9.7%
7 Feb 2017
Lloyd-Smith Malcolm Chief Regulatory Officer
Sold, plan not stated
$5.17K 116 at 44.61
9.7%
6 Feb 2017
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated
$129.97K 3,010 at 43.18
1.2%
6 Feb 2017
OBrien Christopher Flint Chief Medical Officer
Sold, plan not stated
$52.06K 1,206 at 43.17
3.2%
6 Feb 2017
Bozigian Haig P. Chief Development Officer
Sold, plan not stated
$41.54K 963 at 43.14
0.8%
6 Feb 2017
Coughlin Timothy Chief Financial Officer
Sold, plan not stated
$41.54K 963 at 43.14
0.7%
6 Feb 2017
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$35.41K 821 at 43.13
100%
Sold half or more
6 Feb 2017
BENEVICH ERIC Chief Commercial Officer
Sold, plan not stated
$35.39K 821 at 43.11
100%
Sold half or more
6 Feb 2017
Gano Kyle Chief Business Development Off
Sold, plan not stated
$31.37K 727 at 43.15
1.2%
6 Feb 2017
Lloyd-Smith Malcolm Chief Regulatory Officer
Sold, plan not stated
$31.37K 727 at 43.15
100%
Sold half or more
6 Feb 2017
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated
$31.36K 727 at 43.13
0.6%
3 Feb 2017
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated
$132.97K 3,125 at 42.55
1.2%
3 Feb 2017
Coughlin Timothy Chief Financial Officer
Sold, plan not stated
$63.83K 1,500 at 42.55
1.1%
3 Feb 2017
OBrien Christopher Flint Chief Medical Officer
Sold, plan not stated
$63.75K 1,500 at 42.50
4.1%
3 Feb 2017
Bozigian Haig P. Chief Development Officer
Sold, plan not stated
$58.53K 1,375 at 42.57
1.2%
3 Feb 2017
Gano Kyle Chief Business Development Off
Sold, plan not stated
$58.53K 1,375 at 42.57
2.2%
3 Feb 2017
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated
$58.52K 1,375 at 42.56
1.2%
1 Feb 2017
Sold, plan not stated
$454.51K 10,750 at 42.28
43.0%
17 Jan 2017
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated
$152.44K 3,750 at 40.65
1.5%
17 Jan 2017
OBrien Christopher Flint Chief Medical Officer
Sold, plan not stated
$71.16K 1,750 at 40.66
5.0%
17 Jan 2017
Coughlin Timothy Chief Financial Officer
Sold, plan not stated
$71.14K 1,750 at 40.65
1.3%
17 Jan 2017
Gano Kyle Chief Business Development Off
Sold, plan not stated
$66.06K 1,625 at 40.65
2.7%
17 Jan 2017
Bozigian Haig P. Chief Development Officer
Sold, plan not stated
$66.02K 1,625 at 40.63
1.4%
17 Jan 2017
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated
$66.02K 1,625 at 40.63
1.4%
10 Jan 2017
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated
$162.30K 3,750 at 43.28
1.5%
10 Jan 2017
Coughlin Timothy Chief Financial Officer
Sold, plan not stated
$75.90K 1,750 at 43.37
1.3%
10 Jan 2017
OBrien Christopher Flint Chief Medical Officer
Sold, plan not stated
$75.86K 1,750 at 43.35
5.2%
10 Jan 2017
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated
$70.51K 1,625 at 43.39
1.4%
10 Jan 2017
Bozigian Haig P. Chief Development Officer
Sold, plan not stated
$70.48K 1,625 at 43.37
1.4%
10 Jan 2017
Gano Kyle Chief Business Development Off
Sold, plan not stated
$54.21K 1,250 at 43.37
2.1%
15 Nov 2016
OBrien Christopher Flint Chief Medical Officer
Sold, plan not stated
$1.32M 25,000 at 52.84
45.4%
Showing 501–545 of 545. ← Newer Page 11 of 11